Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Intertek Launches Cell-Based Assays | Contract Pharma
Breaking News

Intertek Launches Cell-Based Assays

Manchester services include comprehensive characterization for biologics

Intertek has launched cGMP-compliant cell-based assay services for biologic therapeutics at its European Centre of Excellence for Biopharmaceuticals in Manchester, UK. The cell-based assay services include: method transfer, development and validation, release and stability testing, tracking and trending, and end-point analysis.

“With the addition of tailored cell based assays, Intertek now offers a comprehensive characterization service for biologic therapeutics,” said Ashleigh Wake, Intertek biotechnology team leader. “We will work with our clients to provide a fully validated cell based assay suitable for regulatory submission one which performs reproducibly throughout the entire drug development process.”

“The launch of cell based assays in Europe further demonstrates Intertek’s commitment to support developers and producers of biopharmaceuticals with essential and advanced testing services,” said Dr. Andrew Swift, executive vice president, Intertek Chemicals and Pharmaceuticals, “Our wide technology base and experience in characterizing these complex drug substances and products positions Intertek well to support biologics development worldwide.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters